Name (Synonyms) | Correlation | |
---|---|---|
drug318 | Ciclesonide Inhalation Aerosol Wiki | 1.00 |
drug595 | Hydroxychloroquine + Placebo Wiki | 1.00 |
drug594 | Hydroxychloroquine + Azithromycin Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D011024 | Pneumonia, Viral NIH | 0.14 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.10 |
D003141 | Communicable Diseases NIH | 0.10 |
D011014 | Pneumonia NIH | 0.07 |
D007239 | Infection NIH | 0.07 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.05 |
There is one clinical trial.
Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.
Description: Days
Measure: Proportion of virologically cured (no virus detected) cases at day 6 Time: Day 6Description: Days
Measure: The dichotomous virologic shedding endpoint as assessed at two weeks after study entry Time: 2 weeksDescription: Days
Measure: Quantitative viral load (assessed with each virology testing set) Time: Day 1 to 21